750 related articles for article (PubMed ID: 11360001)
1. Biochemical, electrophysiological and neurohormonal studies with B-20991, a selective 5-HT1A receptor agonist.
Caicoya AG; Beneytez ME; Delgado M; Manzanares J; López-Rodríguez ML; Benhamu B; Morcillo MJ; Pozo MA; Rubia FJ; Fuentes JA
Pharmacology; 2001 May; 62(4):234-42. PubMed ID: 11360001
[TBL] [Abstract][Full Text] [Related]
2. Effects of WAY 100635 and (-)-5-Me-8-OH-DPAT, a novel 5-HT1A receptor antagonist, on 8-OH-DPAT responses.
Trillat AC; Malagié I; Mathé-Allainmat M; Anmela MC; Jacquot C; Langlois M; Gardier AM
Eur J Pharmacol; 1998 Apr; 347(1):41-9. PubMed ID: 9650846
[TBL] [Abstract][Full Text] [Related]
3. Activity of serotonin (5-HT) receptor agonists, partial agonists and antagonists at cloned human 5-HT1A receptors that are negatively coupled to adenylate cyclase in permanently transfected HeLa cells.
Pauwels PJ; Van Gompel P; Leysen JE
Biochem Pharmacol; 1993 Jan; 45(2):375-83. PubMed ID: 8382063
[TBL] [Abstract][Full Text] [Related]
4. Further assessment of the antagonist properties of the novel and selective 5-HT1A receptor ligands (+)-WAY 100 135 and SDZ 216-525.
Lanfumey L; Haj-Dahmane S; Hamon M
Eur J Pharmacol; 1993 Nov; 249(1):25-35. PubMed ID: 8282017
[TBL] [Abstract][Full Text] [Related]
5. Electrophysiological comparison of 5-Hydroxytryptamine1A receptor antagonists on dorsal raphe cell firing.
Martin LP; Jackson DM; Wallsten C; Waszczak BL
J Pharmacol Exp Ther; 1999 Feb; 288(2):820-6. PubMed ID: 9918594
[TBL] [Abstract][Full Text] [Related]
6. 5-HT1A receptor activation and antidepressant-like effects: F 13714 has high efficacy and marked antidepressant potential.
Koek W; Vacher B; Cosi C; Assié MB; Patoiseau JF; Pauwels PJ; Colpaert FC
Eur J Pharmacol; 2001 May; 420(2-3):103-12. PubMed ID: 11408031
[TBL] [Abstract][Full Text] [Related]
7. Estimation of apparent pA2 values for WAY 100635 at 5-HT1A receptors regulating 5-hydroxytryptamine release in anaesthetised rats.
Assié MB; Koek W
Eur J Pharmacol; 2000 Dec; 409(2):173-7. PubMed ID: 11104831
[TBL] [Abstract][Full Text] [Related]
8. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635.
de Boer SF; Lesourd M; Mocaer E; Koolhaas JM
J Pharmacol Exp Ther; 1999 Mar; 288(3):1125-33. PubMed ID: 10027850
[TBL] [Abstract][Full Text] [Related]
9. Electrophysiological examination of the effects of sustained flibanserin administration on serotonin receptors in rat brain.
Rueter LE; Blier P
Br J Pharmacol; 1999 Feb; 126(3):627-38. PubMed ID: 10188973
[TBL] [Abstract][Full Text] [Related]
10. Region-dependent effects of flibanserin and buspirone on adenylyl cyclase activity in the human brain.
Marazziti D; Palego L; Giromella A; Mazzoni MR; Borsini F; Mayer N; Naccarato AG; Lucacchini A; Cassano GB
Int J Neuropsychopharmacol; 2002 Jun; 5(2):131-40. PubMed ID: 12135537
[TBL] [Abstract][Full Text] [Related]
11. 5-HT1A and 5-HT1B receptors control the firing of serotoninergic neurons in the dorsal raphe nucleus of the mouse: studies in 5-HT1B knock-out mice.
Evrard A; Laporte AM; Chastanet M; Hen R; Hamon M; Adrien J
Eur J Neurosci; 1999 Nov; 11(11):3823-31. PubMed ID: 10583471
[TBL] [Abstract][Full Text] [Related]
12. Interactions of lesopitron (E-4424) with central 5-HT1A receptors: in vitro and in vivo studies in the rat.
Haj-Dahmane S; Jolas T; Laporte AM; Gozlan H; Farré AJ; Hamon M; Lanfumey L
Eur J Pharmacol; 1994 Apr; 255(1-3):185-96. PubMed ID: 8026543
[TBL] [Abstract][Full Text] [Related]
13. Anxiolytic-like effect of a serotonergic ligand with high affinity for 5-HT1A, 5-HT2A and 5-HT3 receptors.
Delgado M; Caicoya AG; Greciano V; Benhamú B; López-Rodríguez ML; Fernández-Alfonso MS; Pozo MA; Manzanares J; Fuentes JA
Eur J Pharmacol; 2005 Mar; 511(1):9-19. PubMed ID: 15777774
[TBL] [Abstract][Full Text] [Related]
14. 5-HT1A agonist activity of pindolol: reversal of the inhibitory effects on cell firing in the dorsal raphe nucleus but not in the hippocampus by WAY-100,635.
Sprouse J; Braselton J; Reynolds L
Ann N Y Acad Sci; 1998 Dec; 861():274-5. PubMed ID: 9928287
[No Abstract] [Full Text] [Related]
15. The putative 5-HT1A receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT1A receptor agonist flesinoxan in pigeons.
Mos J; Van Hest A; Van Drimmelen M; Herremans AH; Olivier B
Eur J Pharmacol; 1997 May; 325(2-3):145-53. PubMed ID: 9163561
[TBL] [Abstract][Full Text] [Related]
16. A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635.
Forster EA; Cliffe IA; Bill DJ; Dover GM; Jones D; Reilly Y; Fletcher A
Eur J Pharmacol; 1995 Jul; 281(1):81-8. PubMed ID: 8566121
[TBL] [Abstract][Full Text] [Related]
17. Involvement of somatodendritic 5-HT(1A) receptors in Delta(9)-tetrahydrocannabinol-induced hypothermia in the rat.
Malone DT; Taylor DA
Pharmacol Biochem Behav; 2001; 69(3-4):595-601. PubMed ID: 11509221
[TBL] [Abstract][Full Text] [Related]
18. Role of the medial prefrontal cortex in 5-HT1A receptor-induced inhibition of 5-HT neuronal activity in the rat.
Hajós M; Hajós-Korcsok E; Sharp T
Br J Pharmacol; 1999 Apr; 126(8):1741-50. PubMed ID: 10372816
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
De Vry J; Schohe-Loop R; Heine HG; Greuel JM; Mauler F; Schmidt B; Sommermeyer H; Glaser T
J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
[TBL] [Abstract][Full Text] [Related]
20. Characterization of 4-(2-hydroxyphenyl)-1-[2'-[N-(2''-pyridinyl)-p-fluorobenzamido]ethyl]piperazine (p-DMPPF) as a new potent 5-HT1A antagonist.
Defraiteur C; Plenevaux A; Scuvée-Moreau J; Rouchet N; Goblet D; Luxen A; Seutin V
Br J Pharmacol; 2007 Nov; 152(6):952-8. PubMed ID: 17704821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
